COMP <GO>
MNOV vs CING // OPERATING MARGIN
Medicinova Inc (NASDAQ) VS. Cingulate Inc. (NASDAQ) • 15-METRIC TALLY: MNOV 2
— CING 2
■ METRIC PARITY
LAST: $1.42 (-1.39%) • MKT CAP: $70.9M
operating-margins
-60.00%
LAST: $4.72 (-6.16%) • MKT CAP: $73.1M
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MNOV VS. CING)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MNOV | CING | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -14.24% | -23.06% | +8.82 | MNOV | /fcf-yield <GO> |
| Operating Margin ACTIVE | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 68.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | MNOV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.6 | 53.1 | -11.50 | CING | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 5.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $70.9M | $73.1M | -$2.3M | CING | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MNOV REV | CING REV | MNOV GROSS % | CING GROSS % | MNOV FCF | CING FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $409.7K | $55.8M | — | — | -$9.8M | -$17.4M |
| FY 2024 | $35.5M | $43.8M | — | — | -$10.6M | -$18.7M |
| FY 2023 | $1.0M | $63.7M | — | — | -$7.4M | -$15.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MNOV // BETA —
CING // BETA —